Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2011
02/03/2011WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof
02/03/2011WO2011012957A1 An improved process for the preparation of esomeprazole magnesium dihydrate
02/03/2011WO2011012862A1 Herbicidally active heteroaryl-sυbstitυted cyclic diones or derivatives thereof
02/03/2011WO2011012801A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
02/03/2011WO2011012800A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
02/03/2011WO2011012674A1 Dihydrobenzoindazoles
02/03/2011WO2011012661A1 Pyridine and pyrazine derivatives as protein kinase modulators
02/03/2011WO2011012592A1 Dihydropyrimidone amides as p2x7 modulators
02/03/2011WO2011012269A2 Method and substances for preparation of n-substituted pyridinium compounds
02/03/2011WO2010119078A9 Indole derivative modulators of the alpha 7 nachr
02/03/2011WO2010115491A3 Piperidine and piperazine derivatives as autotaxin inhibitors
02/03/2011WO2010025906A3 Hybrid antimicrobial compounds and their use
02/03/2011US20110028729 Process for preparing aryl-substituted pyrazoles
02/03/2011US20110028728 Process for the preparation of crystalline dexlansoprazole
02/03/2011US20110028716 Dye for a Dye-Sensitised Solar Cell, and a Solar Cell Comprising the Same
02/03/2011US20110028715 Novel adenine compound
02/03/2011US20110028520 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
02/03/2011US20110028519 Small molecule insulin mimetics absent quinones
02/03/2011US20110028518 Dexlansoprazole process and polymorphs
02/03/2011US20110028517 4-methyl-4,5-dihydro-1h-pyrazole-3-carboxamide useful as a cannabinoid cb1 neutral antagonist
02/03/2011US20110028515 New piperidine derivatives
02/03/2011US20110028509 Sulfonamides
02/03/2011US20110028502 Dihydropyrimidone amides as p2x7 modulators
02/03/2011US20110028501 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
02/03/2011US20110028492 Heteroaryl Compounds and Their Uses
02/03/2011US20110028489 Pyrimidine Derivatives and Their Use for Treating Bone-Related Disorders
02/03/2011US20110028486 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
02/03/2011US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors
02/03/2011US20110028482 Isoxazolines as inhibitors of fatty acid amide hydrolase
02/03/2011US20110028476 Proton pump inhibitors
02/03/2011US20110028475 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
02/03/2011US20110028474 Protein kinase and phosphatase inhibitors
02/03/2011US20110028468 Compounds having npy y5 receptor antagonistic activity
02/03/2011US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
02/03/2011US20110028463 Amide compounds
02/03/2011US20110028455 Indole-substituted 3-cyanopyridines As Kinase Inhibitors
02/03/2011US20110028451 Dihydrobenzoindazoles
02/03/2011US20110028447 Indazole derivatives
02/03/2011US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
02/03/2011US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
02/03/2011US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors
02/03/2011US20110028318 Herbicidal compounds based on n-azinyl-n'-pyridylsulphonylureas
02/03/2011US20110027264 Gamma secretase modulators for the treatment of alzheimer's disease
02/03/2011US20110027178 Imaging the central nervous system
02/03/2011US20110024737 Fused polycyclic compound and organic light emitting device having the compound
02/03/2011US20110024725 Anthracene derivatives and organic electronic device using the same
02/03/2011US20110024691 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties
02/03/2011US20110023242 Dichromophore carbonyl or heterocyclic dye, dye composition comprising this dye, process for dyeing keratin materials using this dye
02/03/2011CA2769154A1 Method and substances for preparation of n-substituted pyridinium compounds
02/03/2011CA2768904A1 Dihydrobenzoindazoles
02/03/2011CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof
02/03/2011CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof
02/03/2011CA2768596A1 Herbicidally active heteroaryl-substituted cyclic diones or derivatives thereof
02/03/2011CA2768396A1 Dihydropyrimidone amides as p2x7 modulators
02/03/2011CA2767083A1 Bicyclic compound and use thereof for medical purposes
02/03/2011CA2767066A1 Pyridine and pyrazine derivatives as protein kinase modulators
02/03/2011CA2766515A1 Compounds for the reduction of .beta.-amyloid production
02/02/2011EP2280008A2 Heterocyclic-substituted piperidines as ORL-1 ligands
02/02/2011EP2280003A2 Process for preparing receptor-type kinase modulators
02/02/2011EP2279750A1 Aniline derivative having anti-rna viral activity
02/02/2011EP2279184A1 Indole modulators of the alpha-7 nicotinic acetylcholine receptor
02/02/2011EP2279183A1 Indoles as modulators of nicoticic acetylcholine receptor subtype alpha-7
02/02/2011EP2279177A1 Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/02/2011EP2278973A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
02/02/2011EP2278968A2 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
02/02/2011EP2089369B1 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases
02/02/2011EP1682491B1 Non-symmetrical gelling agent
02/02/2011EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease
02/02/2011EP1606265B1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
02/02/2011EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
02/02/2011EP1288205B1 Novel phenylalanine derivatives
02/02/2011EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/02/2011CN201728103U Imidacloprid reaction kettle
02/02/2011CN101965341A Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies
02/02/2011CN101965338A Novel heterocycles
02/02/2011CN101965337A Novel 1-benzil-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
02/02/2011CN101962379A Method for refining sulfonyl isoquinoline derivative
02/02/2011CN101962365A Aminoindazole derivatives as protein-kinase inhibitors
02/02/2011CN101175725B Process for the preparation of opioid modulators
02/01/2011US7880009 Cinnamide compound
02/01/2011US7880001 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
02/01/2011US7880000 N-(5-(1,1- dimethylethyl)-3- isoxazolyl)-4-methyl-3- ((3-(4-pyrimidinyl)-2- pyridinyl)amino)benzamide, used for treating breast cancer or rheumatoid arthritis
02/01/2011US7879995 organic electroluminescent device has, between a pair of electrodes, at least one organic layer including a light-emitting layer, in which the organic layer contains a specific tetraphenylene compound
02/01/2011US7879902 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof
02/01/2011US7879897 Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives
02/01/2011US7879881 Piperidinyl compounds that selectively bind integrins
02/01/2011US7879880 Substituted aniline derivatives useful as histamine H3 antagonists
02/01/2011US7879879 Biphenyl derivatives
02/01/2011US7879863 Aniline derivatives
02/01/2011US7879857 6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors
02/01/2011US7879856 Diaminothiazoles useful as Axl inhibitors
02/01/2011US7879855 administering (S)-1-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)pyrrolo[1,2-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide, for the treatment of cancers of the colon, lung, ovary, and pancreas; anticarcinogenic agents
02/01/2011US7879851 Viral polymerase inhibitors
02/01/2011US7879850 Organic compounds
02/01/2011US7879839 For treatment and prevention of cardiac arrhythmias; (+-)-2-Morpholin-4-yl-2-phenyl-1,1-dipyridin-3-yl-ethanol; (+-)-2-[(2-methoxyethyl)(methyl)amino]-2-phenyl-1,1-dipyridin-3-ylethanol
02/01/2011CA2688915C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
02/01/2011CA2555633C Non-nucleoside reverse transcriptase inhibitors
02/01/2011CA2551529C Amide derivative and medicine
02/01/2011CA2481055C Combinations of quinolinone derivatives and 5-fu or cpt 11
02/01/2011CA2418656C Proline derivatives and use thereof as drugs